Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1998-06-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0304-4165(98)00036-1PMID 9659366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine and iron induce apoptosis in PC12 cells.

  1997cited by this paper
• Oxidative reactions and schizophrenia: a review-discussion.

  1997cited by this paper
• Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome*

  1997cited by this paper
• Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.

  1997cited by this paper
• Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.

  1997cited by this paper
• Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

  1996cited by this paper
• Oxidative stress and the pathogenesis of Parkinson's disease

  1996cited by this paper
• Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome.

  1996cited by this paper
• Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter.

  1996cited by this paper
• Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase.

  1995cited by this paper
• Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

  1995cited by this paper
• Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase

  1995cited by this paper
• The reaction of superoxide with reduced glutathione.

  1994cited by this paper
• Biochemical and toxicological properties of the oxidation products of catecholamines.

  1992cited by this paper
• Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation.

  1992cited by this paper
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

  1990cited by this paper
• NADPH:cytochrome P-450(c) reductase: Biochemical characterization in rat brain and cultured neurons and evolution of activity during development

  1989cited by this paper
• On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

  1989cited by this paper
• Reaction between ortho-semiquinones and oxygen: pulse radiolysis, electron spin resonance, and oxygen uptake studies.

  1988cited by this paper
• Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry.

  1987cited by this paper
• Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes.

  1985cited by this paper
• Electron spin resonance-spin stabilization of semiquinones produced during oxidation of epinephrine and its analogues.

  1984cited by this paper
• Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography.

  1976cited by this paper
• Electrochemical studies of the oxidation pathways of catecholamines.

  1967cited by this paper
• [69] Lactic dehydrogenase of heart muscle: l(+)-Lactate + DPN ↔ Pyruvate + DPNH + H+

  1955cited by this paper

• Cigarette smoke exposure worsens the severity of alcoholic liver disease by increasing CYP pathway signaling in mice

  2026cites this paper
• A Potential Role of Natural Bioactive Compounds Found in Food in the Prevention of Idiopathic Parkinson’s Disease

  2025cites this paper
• Facile Biological Oxidation of Dopamine to 6-Hydroxydopamine p-Quinone in a Sequential Two-Step Process: Implications for Parkinson's Disease.

  2025cites this paper
• Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model

  2024cites this paper
• The neuroprotective effects of Ferulic acid in toxin-induced models of Parkinson's disease: a review.

  2024cites this paper
• To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease.

  2024cites this paper
• Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease

  2024cites this paper
• A Preclinical Model for Parkinson’s Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies

  2023cites this paper
• Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection

  2023cites this paper
• Hormone-linked redox status and its modulation by antioxidants.

  2023cites this paper
• Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase

  2022cites this paper
• Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson's Disease Biomarkers, in Mammals.

  2022cites this paper
• The effects of biologically important divalent and trivalent metal cations on the cyclization step of dopamine autooxidation reaction: a quantum chemical study

  2022cites this paper
• Preclinical models based on endogenous neurotoxins

  2021cites this paper
• Dopamine and L-Dopa as Selective Endogenous Neurotoxins

  2021cites this paper
• Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach

  2021cites this paper
• Dopamine oxidation to neuromelanin and neurotoxic metabolites

  2021cites this paper
• Neuroprotective mechanisms against dopamine oxidation-dependent neurotoxicity

  2021cites this paper
• Cyclization step of noradrenaline and adrenaline autoxidation: a quantum chemical study

  2020cites this paper
• Cytotoxicity and reactivity of a redox active 1,4-quinone-pyrazole compound and its Ru(II)-p-cymene complex

  2020cites this paper
• Quantum Ensembles of Silicon Nanoparticles: Discrimination of Static and Dynamic Photoluminescence Quenching Processes.

  2019cites this paper
• Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration.

  2019cites this paper
• 10.11 – Quinone Reductases☆

  2018cites this paper
• New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases

  2018cites this paper
• On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo

  2017cites this paper
• Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

  2017influential citation
• Detection of transient dopamine antioxidant radicals using electrochemistry in electrospray ionization mass spectrometry

  2017cites this paper
• Identification of enzymes responsible for nitrazepam metabolism and toxicity in human

  2017cites this paper
• Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson’s disease

  2016cites this paper
• Drug Metabolism and Oxidative Stress: Cellular Mechanism and New Therapeutic Insights

  2016cites this paper
• DT-diaphorase protects astrocytes from aminochrome-induced toxicity.

  2016cites this paper
• Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson's Disease.

  2016cites this paper
• Novel mechanisms of quinone toxicity

  2015cites this paper
• Molecular and Neurochemical Mechanisms Dopamine Oxidation To O-Quinones in Parkinson’s Disease Pathogenesis

  2015cites this paper
• Glutathione Transferase-M2-2 Secreted from Glioblastoma Cell Protects SH-SY5Y Cells from Aminochrome Neurotoxicity

  2015cites this paper
• DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.

  2015cites this paper
• Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update

  2015cites this paper
• Iron and Parkinson's disease.

  2015cites this paper
• In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones.

  2015cites this paper
• Iron Neurotoxicity in Parkinson’s Disease

  2014cites this paper
• Boronic acid ester with dopamine as a tool for bioconjugation and for visualization of cell apoptosis.

  2014cites this paper
• Protective and toxic roles of dopamine in Parkinson's disease

  2014cites this paper
• Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction

  2014cites this paper
• Mechanisms of Dopamine Oxidation and Parkinson’s Disease

  2014cites this paper
• Neurodegeneration from Drugs and Aging‐Derived Free Radicals

  2013cites this paper
• Phosphatidylserine metabolism modification precedes manganese-induced apoptosis and phosphatidylserine exposure in PC12 cells.

  2013cites this paper
• The Role of Prostaglandin H Synthase (PHS) Bioactivation and Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)-Mediated Protection in Endogenous and Methamphetamine-initiated Neurotoxicity

  2013influential citation
• The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1

  2012cites this paper
• Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson’s Disease

  2012cites this paper
• Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity.

  2012cites this paper
• Dopamine Oxidation and Autophagy

  2012cites this paper
• Human prostaglandin H synthase (hPHS)-1- and hPHS-2-dependent bioactivation, oxidative macromolecular damage, and cytotoxicity of dopamine, its precursor, and its metabolites.

  2011cites this paper
• Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.

  2011cites this paper
• Catecholaminergic Cell Lines for the Study of Dopamine Metabolism and Neurotoxicity

  2011cites this paper
• Oxidation chemistry of catecholamines and neuronal degeneration: an update.

  2011cites this paper
• The role of metal ions in dopaminergic neuron degeneration in Parkinsonism and Parkinson’s disease

  2011cites this paper
• Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

  2010cites this paper
• Simultaneous determination of dopamine and its oxidized product (aminochrom), by hydrodynamic amperometry and anodic stripping voltammetry, using the metallic palladium and uranalyl hexacyanoferrate coated aluminum electrodes.

  2010cites this paper
• Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line

  2010cites this paper
• 4.11 – Quinone Reductases

  2010cites this paper
• Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.

  2010cites this paper
• Amelioration of experimental allergic encephalomyelitis (eae) by phase 2 enzyme inducer

  2010cites this paper
• Neurotoxins and neurotoxic species implicated in neurodegeneration

  2009cites this paper
• Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

  2009cites this paper
• Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats

  2009cites this paper
• Role of glycogen synthase kinase-3 in l-DOPA-induced neurotoxicity

  2009cites this paper
• MPP+-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity

  2009cites this paper
• Chapter 4 Molecular Aspects of Neurotoxins in Dopaminergic Neurons

  2009cites this paper
• Roleofglycogensynthase kinase-3inl -DOPA-induced neurotoxicity

  2009cites this paper
• Molecular and Neurochemical Mechanisms in PD Pathogenesis

  2009cites this paper
• Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.

  2009cites this paper
• Involvement of striatal lipid peroxidation and inhibition of calcium influx into brain slices in neurobehavioral alterations in a rat model of short-term oral exposure to manganese.

  2008cites this paper
• Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition.

  2008cites this paper
• Vitamin B2‐sensitized Photo‐oxidation of Dopamine

  2008cites this paper
• TRP-2 expression protects HEK cells from dopamine- and hydroquinone-induced toxicity.

  2008cites this paper
• Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.

  2008cites this paper
• Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson’s disease

  2007cites this paper
• Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component.

  2007cites this paper
• Comparison of cytotoxicity and genotoxicity induced by the extracts of methanol and gasoline engine exhausts.

  2007cites this paper
• Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.

  2007cites this paper
• Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.

  2007cites this paper
• A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132

  2007influential citation
• Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation

  2007cites this paper
• Parkinson's disease: monitoring early diagnosis and disease progression

  2007cites this paper
• A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition

  2006cites this paper
• Nonsteroidal anti-inflammatory drugs in Parkinson’s disease: possible involvement of quinone formation

  2006cites this paper
• One-electron oxidation of catecholamines generates free radicals with an in vitro toxicity correlating with their lifetime.

  2006cites this paper
• Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine.

  2005cites this paper
• Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.

  2005cites this paper
• L-DOPA treatment from the viewpoint of neuroprotection

  2005cites this paper
• Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment.

  2005cites this paper
• Iron accelerates the conversion of dopamine‐oxidized intermediates into melanin and provides protection in SH‐SY5Y cells

  2005cites this paper
• Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra

  2005cites this paper
• Renal-Dose Dopamine: From Hypothesis to Paradigm to Dogma to Myth and, Finally, Superstition?

  2005cites this paper
• Genotoxicity of motorcycle exhaust particles in vivo and in vitro.

  2004cites this paper
• On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation.

  2004cites this paper
• Leucoisoprenochrome-o-semiquinone formation in freshly isolated adult rat cardiomyocytes.

  2004cites this paper
• Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.

  2004influential citation
• Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.

  2004cites this paper
• Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl.

  2003cites this paper